Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTOR
ICCC
Add up to 3 more stocks
CTOR
Citius Oncology, Inc.
-0.41%
$0.87-0.00Delayed quote: Oct 6, 2026, 1:14 PM EDT
Market Cap
$80.88M
52W Range
$0.49 - $2.25
ICCC
ImmuCell Corporation
+0.99%
$9.85+0.10Delayed quote: Oct 6, 2026, 1:09 PM EDT
Market Cap
$89.08M
52W Range
$4.52 - $12.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 116.39 |
| Forward P/E | 8.70 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.00 | 2.84 |
| P/S Ratio | 11.38 | 2.90 |
| P/FCF Ratio | N/A | 21.14 |
| EV/EBITDA | N/A | 14.83 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 40.3% |
| Operating Margin | 0.0% | 12.6% |
| Net Margin | -648.3% | 2.6% |
| ROE | -114.1% | 2.5% |
| ROA | -41.1% | 1.7% |
| ROIC | -88.7% | 8.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.73 | 4.75 |
| Quick Ratio | 0.34 | 2.71 |
| Debt/Equity | 0.25 | 0.40 |
| Interest Coverage | -107.89 | 3.76 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.